Addition of immunomodulating therapy with Thymalin, a thymus agent, to the multimodality therapy of burnt patients contributes to a rapid normalization of immunological parameters. The most marked immune response was observed 7-10 days after a therapy course initiated in the early periods of burn disease in patients with severely depressed T-system immunity and a high sensitivity to the drug. Inclusion of a donor blood leukomass transfusion course activates the cellular link of the immune system just after the treatment course, but fails to favour a stable normalization of thymus-dependent lymphocyte ratios.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[correction immunologic
4
immunologic disorders
4
disorders patients
4
patients burns]
4
burns] addition
4
addition immunomodulating
4
immunomodulating therapy
4
therapy thymalin
4
thymalin thymus
4
thymus agent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!